Mba MBA - Concert Pharmaceuticals CoFounder Chairman
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
Insider
Mba MBA is CoFounder Chairman of Concert Pharmaceuticals
| Age | 69 |
| Phone | 781 860 0045 |
| Web | https://www.concertpharma.com |
Concert Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3853) % which means that it has lost $0.3853 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0868) %, meaning that it created substantial loss on money invested by shareholders. Concert Pharmaceuticals' management efficiency ratios could be used to measure how well Concert Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Concert Pharmaceuticals currently holds 14.51 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. Concert Pharmaceuticals has a current ratio of 9.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Concert Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeff Stotland | Hudson Pacific Properties | N/A | |
| CFA CFA | Playa Hotels Resorts | N/A | |
| Michael Hyter | Dine Brands Global | 64 | |
| Kevin Schiff | Weyco Group | 55 | |
| Timothy Naughton | Park Hotels Resorts | 59 | |
| Gregory Bever | Dine Brands Global | N/A | |
| Geoffrey Garrett | Park Hotels Resorts | 62 | |
| Brian Flannery | Weyco Group | 62 | |
| Andr Gerondeau | Meli Hotels International | N/A | |
| Thomas Morey | Park Hotels Resorts | 52 | |
| Stephane Baos | Meli Hotels International | N/A | |
| Judy Anderson | Weyco Group | 56 | |
| Lourdes Ripoll | Meli Hotels International | N/A | |
| Christie Kelly | Park Hotels Resorts | 59 | |
| Nancy Vu | Park Hotels Resorts | 48 | |
| Patricia Bedient | Park Hotels Resorts | 67 | |
| Stephen Sadove | Park Hotels Resorts | 69 | |
| Joseph Lieberman | Park Hotels Resorts | 79 | |
| Martha Poulter | Dine Brands Global | 53 | |
| Christine Son | Dine Brands Global | 49 | |
| William Combs | Weyco Group | N/A | |
Management Performance
| Return On Equity | -1.09 | |||
| Return On Asset | -0.39 |
Concert Pharmaceuticals Leadership Team
Elected by the shareholders, the Concert Pharmaceuticals' board of directors comprises two types of representatives: Concert Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Concert. The board's role is to monitor Concert Pharmaceuticals' management team and ensure that shareholders' interests are well served. Concert Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Concert Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nancy Stuart, Chief Officer | ||
| James Cassella, Senior Vice President chief development officer | ||
| Marc Becker, Chief Officer | ||
| Christine Boisclair, Vice President - Regulatory Affairs | ||
| Justine Koenigsberg, VP of Corporate Communications and Investor Relations | ||
| Jeffrey Munsie, Chief Sec | ||
| Nabil PharmD, VP Devel | ||
| Roger Tung, Co-Founder, CEO and President and Director | ||
| Mba MBA, CoFounder Chairman |
Concert Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Concert Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.09 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (2.88) % | |||
| Current Valuation | 86.63 M | |||
| Shares Outstanding | 48.02 M | |||
| Shares Owned By Insiders | 3.77 % | |||
| Shares Owned By Institutions | 77.05 % | |||
| Number Of Shares Shorted | 1.08 M | |||
| Price To Earning | 3.08 X | |||
| Price To Book | 1.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |